Repligen (RGEN)
(Delayed Data from NSDQ)
$122.30 USD
-2.08 (-1.67%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $122.21 -0.09 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Repligen Corporation has a market cap of $7.00B, which represents its share price of $124.38 multiplied by its outstanding shares number of 56.26M. As a mid-cap company, RGEN's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RGEN 122.30 -2.08(-1.67%)
Will RGEN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RGEN
Do Options Traders Know Something About Repligen Stock We Don't?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
RGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Repligen (RGEN) Lags Q2 Earnings Estimates
Here's Why Repligen (RGEN) is a Strong Growth Stock
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't?
Other News for RGEN
RGEN Crossed Above 20 Day Moving Average on September 19
Is RGEN showing upside potential? Directional Movement Crossover Bullish shows up after sinking 0.3%
Regenera Inc. Announces Private Placement to Raise $236,192
Is RGEN likely to continue higher? Pocket Pivot shows up after rallying 5.28%
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Repligen (RGEN) and Exelixis (EXEL)